Amarin Corp Plc (AMRN)

[bogatie]

ICER Page 40

To allay fears posted here in last 30 minutes, here is the ICER summary on mineral oil (Page 40):

Although we are uncertain whether the use of mineral oil may have caused some harm to the placebo group, we do not believe that this theory can account for the entire benefit observed in the REDUCE-IT trial. We believe that the results of REDUCE-IT likely apply across a range of baseline triglyceride levels, but are uncertain whether the results generalize to patients not treated with statins. For adults with established CVD or at high risk of cardiovascular events who are being treated with statins, we have high certainty that icosapent ethyl provides a small-to-substantial net health benefit (“B+”).